Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Since Newton witnessed a bubble rising from his bathtub, mankind has sought the stars. When William III of England commissioned Capt. William Kidd to command the first expedition to Mars in the late 1600s, he proved that space travel was both possible and profitable. Find out more at http://us.macmillan.com/arabellaofmars/daviddlevine-1 Arabella of Mars by David E Levine. Fantasy
Stashimi Inc., a new LA-based music, news and entertainment group dedicated to saving our collective attention spans, today announced that it will be releasing its flagship mobile app in conjunction with a signature event series dedicated to supporting emerging artists.
Working with a diverse list of rising talents like Mr. Carmack, Terrace Martin, Jesse Boykins III, SOSUPERSAM, Yung Jake and more, Stashimi will host producer workshops, EP releases, intimate shows with incredible lineups, and a touring university lecture series with former NPR hip-hop podcast Microphone Check, created by Ali Shaheed Muhammad (A Tribe Called Quest) and journalist Frannie Kelley.
"Artists drive culture, and Stashimi honors and reinforces that. Stashimi respects journalism, even thinks it’s necessary, but its allegiance is to the musician. And we second that emotion,” says Frannie Kelley and Ali Shaheed Muhammad.
To view the multimedia release go to:
http://www.multivu.com/players/English/7931251-stashimi-music-news-app-launch/
Since Newton witnessed a bubble rising from his bathtub, mankind has sought the stars. When William III of England commissioned Capt. William Kidd to command the first expedition to Mars in the late 1600s, he proved that space travel was both possible and profitable.
The Adventures of Arabella Ashby series by David D. Levine, beginning with Arabella of Mars and continuing in Arabella and the Battle of Venus, offers adventure, romance, political intrigue, and Napoleon in space!
Find out more at- https://us.macmillan.com/series/theadventuresofarabellaashby Scifi/Fantasy
At the start of year-end reporting season, businesses can find themselves facing many questions about forms and deadlines. With the introduction of the Affordable Care Act in 2014, the waters got even muddier.
Greatland Corporation, an expert in forms and reporting, has developed a helpful outline for businesses facing reporting questions.
• If your business employs 50 or more full-time equivalent employees and is self-insured, you need to file Form 1095-C Parts I, II and III.
• If your business employs 50 or more full-time equivalent employees and you are NOT self-insured, you need to file Form 1095-C Parts I and II only.
• If you are a self-insured employer with less than 50 full-time equivalent employees, you are required to file Form 1095-B, Parts I, III and IV.
To view the multimedia release go to:
https://www.multivu.com/players/English/8218651-greatland-corporation-year-end-tax-reporting-advice/
